115 related articles for article (PubMed ID: 10096250)
1. Over-expression and amplification of the c-myc gene in human urothelial carcinoma.
Christoph F; Schmidt B; Schmitz-Dräger BJ; Schulz WA
Int J Cancer; 1999 Apr; 84(2):169-73. PubMed ID: 10096250
[TBL] [Abstract][Full Text] [Related]
2. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
Sauter G; Carroll P; Moch H; Kallioniemi A; Kerschmann R; Narayan P; Mihatsch MJ; Waldman FM
Am J Pathol; 1995 May; 146(5):1131-9. PubMed ID: 7747807
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and amplification of c-myc during progression of human colorectal cancer.
Rochlitz CF; Herrmann R; de Kant E
Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
[TBL] [Abstract][Full Text] [Related]
5. c-myc in bladder cancer. Clinical findings and analysis of mechanism.
Schmitz-Dräger BJ; Schulz WA; Jürgens B; Gerharz CD; van Roeyen CR; Bültel H; Ebert T; Ackermann R
Urol Res; 1997; 25 Suppl 1():S45-9. PubMed ID: 9079756
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.
Wu R; Lin L; Beer DG; Ellenson LH; Lamb BJ; Rouillard JM; Kuick R; Hanash S; Schwartz DR; Fearon ER; Cho KR
Am J Pathol; 2003 May; 162(5):1603-10. PubMed ID: 12707044
[TBL] [Abstract][Full Text] [Related]
7. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
8. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
Iwakawa R; Kohno T; Kato M; Shiraishi K; Tsuta K; Noguchi M; Ogawa S; Yokota J
Clin Cancer Res; 2011 Mar; 17(6):1481-9. PubMed ID: 21148746
[TBL] [Abstract][Full Text] [Related]
9. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.
Stasik CJ; Nitta H; Zhang W; Mosher CH; Cook JR; Tubbs RR; Unger JM; Brooks TA; Persky DO; Wilkinson ST; Grogan TM; Rimsza LM
Haematologica; 2010 Apr; 95(4):597-603. PubMed ID: 20378577
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer.
Sardi I; Dal Canto M; Bartoletti R; Guazzelli R; Travaglini F; Montali E
Eur Urol; 1998; 33(4):424-30. PubMed ID: 9612689
[TBL] [Abstract][Full Text] [Related]
11. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
13. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
[TBL] [Abstract][Full Text] [Related]
14. High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer.
Zaharieva B; Simon R; Ruiz C; Oeggerli M; Mihatsch MJ; Gasser T; Sauter G; Toncheva D
Int J Cancer; 2005 Dec; 117(6):952-6. PubMed ID: 15986448
[TBL] [Abstract][Full Text] [Related]
15. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
16. Quantification of changes in c-myc mRNA levels in normal human bronchial epithelial (NHBE) and lung adenocarcinoma (A549) cells following chemical treatment.
Fields WR; Desiderio JG; Putnam KP; Bombick DW; Doolittle DJ
Toxicol Sci; 2001 Sep; 63(1):107-14. PubMed ID: 11509750
[TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
[TBL] [Abstract][Full Text] [Related]
18. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
19. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
20. Deregulation in trans or c-myc expression in immortalized human urothelial cells and in T24 bladder carcinoma cells.
Stacey SN; Nielsen I; Skouv J; Hansen C; Autrup H
Mol Carcinog; 1990; 3(4):216-25. PubMed ID: 1698381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
